Media Summary: Christine Pechera had been diagnosed with non- Alex Herrera, M.D., shares results from SWOG S1826, a randomized study of nivolumab-AVD versus brentuximab vedotin-AVD in ... May 2022 - Dr. Steven Rosen joined Susan Thornton to share his story about becoming a clinician and his experience treating ...

The Stephensons Conquering Lymphoma Together City Of Hope - Detailed Analysis & Overview

Christine Pechera had been diagnosed with non- Alex Herrera, M.D., shares results from SWOG S1826, a randomized study of nivolumab-AVD versus brentuximab vedotin-AVD in ... May 2022 - Dr. Steven Rosen joined Susan Thornton to share his story about becoming a clinician and his experience treating ... Dr Steven Rosen, City of Hope (Leukemia & Lymphoma Society) Dr. Popplewell, Associate Clinical Professor, Department of Hematology and Hematopoietic Cell Transplantation, Toni ... Visit Our Website: Follow us on Facebook:

Dr. Steven T. Rosen is the Provost and Chief Scientific Officer and Direct of Comprehensive Steven Rosen, MD, Chief Scientific Officer of the

Photo Gallery

The Stephensons - Conquering Lymphoma Together | City of Hope
I Am a Miracle: Christine, Lymphoma Survivor  | City of Hope
Breakthrough Study for Advanced Stage Classic Hodgkin Lymphoma | ASCO 2023
City of Hope receives historic $150 million gift
Understanding Hodgkin Lymphoma | The Balancing Act
Hodgkin Lymphoma with Dr. Robert Chen @ City of Hope
The Miracle of Science with Soul - Christine's Story | City of Hope
Managing patients with non-Hodgkin lymphoma
Non-hodgkin lymphoma advances in 2018
City of Hope Hematologist/Oncologist Dr. Alex Herrera shares symptoms and statistics for Blood Cance
Fireside Chat with Dr. Steven Rosen
City of Hope receives historic $150 million gift
Sponsored
Sponsored
View Detailed Profile
The Stephensons - Conquering Lymphoma Together | City of Hope

The Stephensons - Conquering Lymphoma Together | City of Hope

Lymphoma

I Am a Miracle: Christine, Lymphoma Survivor  | City of Hope

I Am a Miracle: Christine, Lymphoma Survivor | City of Hope

Christine Pechera had been diagnosed with non-

Sponsored
Breakthrough Study for Advanced Stage Classic Hodgkin Lymphoma | ASCO 2023

Breakthrough Study for Advanced Stage Classic Hodgkin Lymphoma | ASCO 2023

Alex Herrera, M.D., shares results from SWOG S1826, a randomized study of nivolumab-AVD versus brentuximab vedotin-AVD in ...

City of Hope receives historic $150 million gift

City of Hope receives historic $150 million gift

City of Hope

Understanding Hodgkin Lymphoma | The Balancing Act

Understanding Hodgkin Lymphoma | The Balancing Act

Behind the Mystery is on location at

Sponsored
Hodgkin Lymphoma with Dr. Robert Chen @ City of Hope

Hodgkin Lymphoma with Dr. Robert Chen @ City of Hope

New Treatment for

The Miracle of Science with Soul - Christine's Story | City of Hope

The Miracle of Science with Soul - Christine's Story | City of Hope

Christine Pechera had been diagnosed with non-

Managing patients with non-Hodgkin lymphoma

Managing patients with non-Hodgkin lymphoma

At the iwNHL 2014, Dr Steven Rosen (

Non-hodgkin lymphoma advances in 2018

Non-hodgkin lymphoma advances in 2018

Steven Rosen, MD, from the

City of Hope Hematologist/Oncologist Dr. Alex Herrera shares symptoms and statistics for Blood Cance

City of Hope Hematologist/Oncologist Dr. Alex Herrera shares symptoms and statistics for Blood Cance

In honor of Blood

Fireside Chat with Dr. Steven Rosen

Fireside Chat with Dr. Steven Rosen

May 2022 - Dr. Steven Rosen joined Susan Thornton to share his story about becoming a clinician and his experience treating ...

City of Hope receives historic $150 million gift

City of Hope receives historic $150 million gift

City of Hope

Diffuse Large B-Cell Lymphoma Survivor Shares Novel Therapy

Diffuse Large B-Cell Lymphoma Survivor Shares Novel Therapy

After a diffuse large B-cell

Dr Steven Rosen, City of Hope (Leukemia & Lymphoma Society)

Dr Steven Rosen, City of Hope (Leukemia & Lymphoma Society)

Dr Steven Rosen, City of Hope (Leukemia & Lymphoma Society)

Critical insight into therapeutic progress for CTCL

Critical insight into therapeutic progress for CTCL

Steven Rosen, MD, of the

Adaptive Immunotherapy Research | City of Hope

Adaptive Immunotherapy Research | City of Hope

City of Hope's

Leslie Popplewell, MD, summarizes the role of checkpoint inhibitors in the treatment of lymphomas

Leslie Popplewell, MD, summarizes the role of checkpoint inhibitors in the treatment of lymphomas

Dr. Popplewell, Associate Clinical Professor, Department of Hematology and Hematopoietic Cell Transplantation, Toni ...

Lymphoma: Full Length With Captions

Lymphoma: Full Length With Captions

Visit Our Website: https://www.CityOfHope.org/OC Follow us on Facebook:

Meet Cancer Center Director Steven T. Rosen, M.D. | City of Hope

Meet Cancer Center Director Steven T. Rosen, M.D. | City of Hope

Dr. Steven T. Rosen is the Provost and Chief Scientific Officer and Direct of Comprehensive

Management & research for CTCL at the City of Hope

Management & research for CTCL at the City of Hope

Steven Rosen, MD, Chief Scientific Officer of the